We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland.
- Authors
Hermanowski, Tomasz; Szafraniec-Burylo, Sylwia I.; Ceglowska, Urszula; Drozdowska, Aleksandra; Duleba, Dominika; Kowalczyk, Marta; Krancberg, Aleksandra N.; Pashos, Chris L.; Szczypior, Andrzej; Chmielewska, Malgorzata; Czech, Marcin
- Abstract
The abstract presents results of the "InterQuality Project - International Research Project on Financing Quality in Healthcare" funded by the 7th Framework Programme (FP7) for Research and Technological Development of the European Union. Grant Agreement No: HEALTH-F3-2010-261369 Objective: To assess reliability, validity and completeness of data on pharmaceutical benefit financing components of health care in United States, United Kingdom, Denmark, Germany, Italy and Poland Theory: Information and guidance used by authorities for decision making in the financing of pharmaceutical care should be reliable, valid and complete. Methods: A systematic review of literature published in the last 10 years, found electronically in Medline, Embase, the Cochrane Library and SCOPUS, supplemented by a manual search, was conducted. Quality of publications was critically appraised using PRISMA [1], MOOSE [2] and STROBE [3] checklists. Contents of found literature were assessed in terms of consistency, coherence and strength. Results: In total, 439 full text publications were included, of which 198 papers were assessed for quality. Of these, 24,6%, 31,2% and 22,1% publications presented high levels of: consistency, coherence and strength, respectively, and 4,3% presented concurrently high levels of all assessed areas. Several areas of weak data availability were identified. Discussion: No comparable analyses were found. Credible data were often unavailable. A questionnaire and a template helpful to collect data where more information is needed were developed, validated and will be sent to experts from InterQuality Consortium countries. Conclusion: To improve the quality of information available to decision makers, so that it is more credible, multiple sources should be used.
- Subjects
GERMANY; DENMARK; POLAND; ITALY; PHARMACEUTICAL industry
- Publication
International Journal of Integrated Care (IJIC), 2013, Vol 13, p1
- ISSN
1568-4156
- Publication type
Article